PAVmed Inc.
PAVM
$0.5757
$0.00971.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -20.00% | -99.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.00% | -99.00% | |||
| Cost of Revenue | -25.00% | -96.52% | |||
| Gross Profit | 26.32% | 90.13% | |||
| SG&A Expenses | 6.66% | -54.62% | |||
| Depreciation & Amortization | -- | -100.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.95% | -58.67% | |||
| Operating Income | -4.99% | 55.20% | |||
| Income Before Tax | 1,530.74% | -98.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1,530.74% | -98.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 19.38% | -92.16% | |||
| Net Income | 1,225.51% | -97.78% | |||
| EBIT | -4.99% | 55.20% | |||
| EBITDA | -5.57% | 54.87% | |||
| EPS Basic | 925.91% | -98.07% | |||
| Normalized Basic EPS | -33.33% | 81.06% | |||
| EPS Diluted | 2,886.89% | -100.85% | |||
| Normalized Diluted EPS | -327.08% | 93.05% | |||
| Average Basic Shares Outstanding | 28.15% | 8.22% | |||
| Average Diluted Shares Outstanding | -60.22% | 196.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||